Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

類似資料

• Dual inhibition of EGFR and mTOR pathways in small cell lung cancer
  著者:: Schmid, K, 等
  出版事項: (2010)
• Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
  著者:: Erlich, R B, 等
  出版事項: (2012)
• The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models
  著者:: D'Amato, V, 等
  出版事項: (2014)
• Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
  著者:: Bianco, R, 等
  出版事項: (2008)
• Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR
  著者:: Schayowitz, A, 等
  出版事項: (2010)